Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Tan, Susanne ^a   Scherag, André ^a   Janssen, Onno E ^b   Hahn, Susanne ^c   Lahner, Harald ^a   Dietz, Tiina ^a   Scherag, Susann ^a   Grallert, Harald ^d   Vogel, Carla I G ^a   Kimmig, Rainer ^a   Illig, Thomas ^d   Mann, Klaus ^a   Hebebrand, Johannes ^a   Hinney, Anke ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ENDOKRINOLOGIKUM HAMBURG   (Germany)

^c Center for Endocrine and Metabolic Diseases   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MELANOCORTIN 4 RECEPTOR; OBESITY ASSOCIATED PROTEIN; PROTEIN FTO; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; FTO PROTEIN, HUMAN; INSIG2 PROTEIN, HUMAN; MC4R PROTEIN, HUMAN; MEMBRANE PROTEIN; PRIMER DNA; PROTEIN; SIGNAL PEPTIDE; T CELL FACTOR PROTEIN; TCF7L2 TRANSCRIPTION FACTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; GENETICS; INTRON; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; BASE SEQUENCE; BODY MASS INDEX; DNA PRIMERS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRONS; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; TCF TRANSCRIPTION FACTORS;

EID: 77349091596     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-12     Document Type: Article

References (58)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89:2745-2749. 10.1210/jc.2003-032046, 15181052.
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
3. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992, 36:105-111. 10.1111/j.1365-2265.1992.tb02909.x, 1559293.
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989, 38:1165-1174. 10.2337/diabetes.38.9.1165, 2670645.
5. Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S, Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1996, 81:1979-1983. 10.1210/jc.81.5.1979, 8626868.
6. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 2001, 281:E392-399.
7. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002, 78:569-576. 10.1016/S0015-0282(02)03275-2, 12215335.
8. Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss JF, Dunaif A, Spielman RS. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 2006, 91:4112-4117. 10.1210/jc.2006-0951, 16868051.
9. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894. 10.1126/science.1141634, 2646098, 17434869.
10. Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, Muller TD, Grallert H, Illig T, Wichmann HE, Rief W, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2007, 2:e1361. 10.1371/journal.pone.0001361, 2137937, 18159244.
11. Pascoe L, Tura A, Patel SK, Ibrahim IM, Ferrannini E, Zeggini E, Weedon MN, Mari A, Hattersley AT, McCarthy MI, et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007, 56:3101-3104. 10.2337/db07-0634, 17804762.
12. Barber TM, Bennett AJ, Groves CJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Elliott P, Lindgren CM, et al. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 2008, 51:1153-1158. 10.1007/s00125-008-1028-6, 18478198.
13. Attaoua R, Ait El Mkadem S, Radian S, Fica S, Hanzu F, Albu A, Gheorghiu M, Coculescu M, Grigorescu F. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochem Biophys Res Commun 2008, 373:230-234. 10.1016/j.bbrc.2008.06.039, 18572014.
14. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, et al. A common genetic variant is associated with adult and childhood obesity. Science 2006, 312:279-283. 10.1126/science.1124779, 16614226.
15. Kumar J, Sunkishala RR, Karthikeyan G, Sengupta S. The common genetic variant upstream of INSIG2 gene is not associated with obesity in Indian population. Clin Genet 2007, 71:415-418. 10.1111/j.1399-0004.2007.00795.x, 17489846.
16. Loos RJ, Barroso I, O'Rahilly S, Wareham NJ. Comment on "A common genetic variant is associated with adult and childhood obesity". Science 2007, 315:187. 10.1126/science.1130012, 2719286, 17218509.
17. Dina C, Meyre D, Samson C, Tichet J, Marre M, Jouret B, Charles MA, Balkau B, Froguel P. Comment on "A common genetic variant is associated with adult and childhood obesity". Science 2007, 315:187. 10.1126/science.1129402, 17218508.
18. Rosskopf D, Bornhorst A, Rimmbach C, Schwahn C, Kayser A, Kruger A, Tessmann G, Geissler I, Kroemer HK, Volzke H. Comment on "A common genetic variant is associated with adult and childhood obesity". Science 2007, 315:187. 10.1126/science.1130571, 17218510.
19. Lyon HN, Emilsson V, Hinney A, Heid IM, Lasky-Su J, Zhu X, Thorleifsson G, Gunnarsdottir S, Walters GB, Thorsteinsdottir U, et al. The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet 2007, 3:e61. 10.1371/journal.pgen.0030061, 1857727, 17465681.
20. Reinehr T, Hinney A, Nguyen TT, Hebebrand J. Evidence of an influence of a polymorphism near the INSIG2 on weight loss during a lifestyle intervention in obese children and adolescents. Diabetes 2008, 57:623-626. 10.2337/db07-0408, 18003761.
21. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323. 10.1038/ng1732, 16415884.
22. Meigs JB, Manning AK, Fox CS, Florez JC, Liu C, Cupples LA, Dupuis J. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet 2007, 8(Suppl 1):S16. 10.1186/1471-2350-8-S1-S16, 1995610, 17903298.
23. Lyssenko V, Lupi R, Marchetti P, Del S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163. 10.1172/JCI30706, 1934596, 17671651.
24. Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab 2008, 93:304-309. 10.1210/jc.2007-1225, 2190750, 17971425.
25. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005, 280:1457-1464. 10.1074/jbc.M411487200, 15525634.
26. Deacon CF. Therapeutic strategies based on glucagon-like peptide 1. Diabetes 2004, 53:2181-2189. 10.2337/diabetes.53.9.2181, 15331525.
27. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885. 10.1038/nature05616, 17293876.
28. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007, 39:218-225. 10.1038/ng1960, 17206141.
29. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjogren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895. 10.2337/db06-0381, 17003358.
30. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V, et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006, 55:2903-2908. 10.2337/db06-0474, 17003360.
31. Barber TM, Bennett AJ, Groves CJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Elliott P, Wass JA, et al. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 2007, 50:2318-2322. 10.1007/s00125-007-0804-z, 17805508.
32. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, et al. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004, 74:572-581. 10.1086/382490, 1193776, 14973783.
33. Heid IM, Vollmert C, Hinney A, Doring A, Geller F, Lowel H, Wichmann HE, Illig T, Hebebrand J, Kronenberg F. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 2005, 42:e21. 10.1136/jmg.2004.027011, 1736034, 15805150.
34. Young EH, Wareham NJ, Farooqi S, Hinney A, Hebebrand J, Scherag A, O'Rahilly S, Barroso I, Sandhu MS. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond) 2007, 31:1437-1441. 10.1038/sj.ijo.0803609, 2683751, 17356525.
35. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775. 10.1038/ng.140, 2669167, 18454148.
36. Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, Balding D, Scott J, Kooner JS. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008, 40:716-718. 10.1038/ng.156, 18454146.
37. Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, Schmidt M, Elsenbruch S, Kimmig R, Mann K, Janssen OE. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 2007, 157:669-676. 10.1530/EJE-07-0294, 17984248.
38. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84:3666-3672. 10.1210/jc.84.10.3666, 10523012.
39. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999, 48:1779-1786. 10.2337/diabetes.48.9.1779, 10480608.
40. Holle R, Happich M, Lowel H, Wichmann HE. KORA--a research platform for population based health research. Gesundheitswesen 2005, 67(Suppl 1):S19-25. 10.1055/s-2005-858235, 16032513.
41. Vollmert C, Windl O, Xiang W, Rosenberger A, Zerr I, Wichmann HE, Bickeboller H, Illig T, Kretzschmar HA. Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet 2006, 43:e53. 10.1136/jmg.2006.040931, 2563174, 17047093.
42. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
43. Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008, 9:45. 10.1186/1471-2350-9-45, 2412856, 18498634.
44. Stolerman ES, Manning AK, McAteer JB, Fox CS, Dupuis J, Meigs JB, Florez JC. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009, 52:614-620. 10.1007/s00125-009-1266-2, 19183934.
45. Rizzo M, Berneis K, Hersberger M, Pepe I, Di G, Rini GB, Spinas GA, Carmina E. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 2009, 24:2286-2292. 10.1093/humrep/dep121, 19454589.
46. Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol 2008, 198:670. 10.1016/j.ajog.2008.01.037, 18355776.
47. Barber TM, Wass JA, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007, 66:513-517.
48. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006, 91:3922-3927. 10.1210/jc.2006-1054, 16849400.
49. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orru M, Usala G, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3:e115. 10.1371/journal.pgen.0030115, 1934391,1934391, 17658951.
50. Kowalska I, Malecki MT, Straczkowski M, Skupien J, Karczewska-Kupczewska M, Nikolajuk A, Szopa M, Adamska A, Wawrusiewicz-Kurylonek N, Wolczynski S, et al. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab 2009, 35(4):328-31. 10.1016/j.diabet.2009.03.004, 19625203.
51. Horikoshi M, Hara K, Ito C, Shojima N, Nagai R, Ueki K, Froguel P, Kadowaki T. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007, 50:2461-2466. 10.1007/s00125-007-0827-5, 17928989.
52. Wahlen K, Sjolin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res 2008, 49:607-611. 10.1194/jlr.M700448-JLR200, 18048838.
53. Marzi C, Huth C, Kolz M, Grallert H, Meisinger C, Wichmann HE, Rathmann W, Herder C, Illig T. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 2007, 39:46-52. 10.1055/s-2007-957345, 17226113.
54. Melzer D, Murray A, Hurst AJ, Weedon MN, Bandinelli S, Corsi AM, Ferrucci L, Paolisso G, Guralnik JM, Frayling TM. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 2006, 4:34. 10.1186/1741-7015-4-34, 1769391, 17181866.
55. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, Frayling TM, Yajnik CS. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 2007, 50:63-67. 10.1007/s00125-006-0502-2, 17093941.
56. Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S, Wareham NJ. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 2007, 56:1943-1947. 10.2337/db07-0055, 2668957, 17416797.
57. Florez JC, Jablonski KA, Bayley N, Pollin TI, de PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006, 355:241-250. 10.1056/NEJMoa062418, 1762036, 16855264.
58. Pascoe L, Frayling TM, Weedon MN, Mari A, Tura A, Ferrannini E, Walker M. Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Diabetologia 2008, 51:1989-1992. 10.1007/s00125-008-1124-7, 18719881.